Yuhan Corporation (KRX:000100)
107,900
-300 (-0.28%)
At close: Jan 16, 2026
Yuhan Market Cap
Yuhan has a market cap or net worth of 8.05 trillion as of January 16, 2026. Its market cap has decreased by -4.64% in one year.
Market Cap
8.05T
Enterprise Value
8.07T
Revenue
2.14T
Ranking
n/a
PE Ratio
126.31
Stock Price
107,900.00
Market Cap Chart
Since April 26, 2001, Yuhan's market cap has increased from 231.73B to 8.05T, an increase of 3,375.95%. That is a compound annual growth rate of 15.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 8.05T | -4.00% |
| Dec 30, 2025 | 8.39T | -6.18% |
| Dec 30, 2024 | 8.94T | 73.59% |
| Dec 28, 2023 | 5.15T | 25.86% |
| Dec 29, 2022 | 4.09T | -3.94% |
| Dec 30, 2021 | 4.26T | -9.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 90.13T |
| Celltrion | 45.73T |
| ALTEOGEN | 27.70T |
| ABL Bio | 10.89T |
| SK Biopharmaceuticals | 9.43T |
| HLB Co., Ltd. | 6.97T |
| Sam Chun Dang Pharm. | 6.49T |
| LigaChem Biosciences | 6.07T |